25I-NBF (2C-I-NBF NBF-2C-I Cimbi-21) is a derivative of the phenethylamine hallucinogen 2C-I which acts as a highly potent partial agonist for the human 5-HT2A receptor. It has been studied in its 11C radiolabelled form as a potential ligand for mapping the distribution of 5-HT2A receptors in the brain using positron emission tomography (PET).
This page contains content from the copyrighted Wikipedia article "25I-NBF"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
